Filing Details
- Accession Number:
- 0001209191-21-025495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-05 19:45:22
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-05 19:45:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1796280 | Oric Pharmaceuticals Inc. | ORIC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1214133 | H Richard Scheller | C/O Oric Pharmaceuticals, Inc. 240 E. Grand Ave., 2Nd Floor South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-01 | 200 | $25.00 | 49,800 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
